Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P McNally

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2013
Eliminating encephalitogenic T cells without undermining protective immunityJonathan P McNally, Eileen E Elfers, Catherine E Terrell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligandsAudrey L Kinter, Emily J Godbout, Jonathan P McNally, et al.
Diabetes|August 15, 2018
Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T CellsKaitlin R Carroll, Eileen E Elfers, Joseph J Stevens, et al.
Plos Pathogens|March 9, 2011
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmissionFatima Nawaz, Claudia Cicala, Donald Van Ryk, et al.
Current Opinion in Virology|November 23, 2015
Roles of natural killer cells in antiviral immunityStephen N Waggoner, Seth D Reighard, Ivayla E Gyurova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2009
The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1Claudia Cicala, Elena Martinelli, Jonathan P McNally, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2013
Eliminating encephalitogenic T cells without undermining protective immunityJonathan P McNally, Eileen E Elfers, Catherine E Terrell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligandsAudrey L Kinter, Emily J Godbout, Jonathan P McNally, et al.
Diabetes|August 15, 2018
Extending Remission and Reversing New-Onset Type 1 Diabetes by Targeted Ablation of Autoreactive T CellsKaitlin R Carroll, Eileen E Elfers, Joseph J Stevens, et al.
Plos Pathogens|March 9, 2011
The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmissionFatima Nawaz, Claudia Cicala, Donald Van Ryk, et al.
Current Opinion in Virology|November 23, 2015
Roles of natural killer cells in antiviral immunityStephen N Waggoner, Seth D Reighard, Ivayla E Gyurova, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2009
The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1Claudia Cicala, Elena Martinelli, Jonathan P McNally, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
Pageof 1